Epstein Secrets

ficate of incorporation and our amended and restated voting agreement, our directors were elected as follows: Messrs. Dorsey, McKelvey. Khosla, and Johnson and Drs. Summers and Simmons were elected as the designees nominated by holders of our common stock; Mr. Botha was elected as the designee nominate

nated by holders of our common stock; Mr. Botha was elected as the designee nominated by holders of our Series B convertible preferred stock; • Ms. Meeker was elected as the designee nominated by holders of our Series C convertible preferred stock; and • Mr. Viniar was elected as a designee nominated b

dards of the New York Stock Exchange. Nominating and Corporate Governance Committee Our nominating and governance committee is comprised of Messrs. Johnson and Viniar and Dr. Simmons, each of whom satisfies the requirements for independence under the applicable rules and regulations of the SEC and listi

S-1/A Table of Contents Compensation Committee Our compensation committee is comprised of Ms. Meeker and Mr. Botha, each of whom satisfies the requirements for independence under the applicable rules and regulations of the SEC and listing standards

of such change of control. As of December 31, 2014, Mr. Viniar held an option to purchase 326,950 shares of our common stock. On July 9, 2015, Mr. Johnson was granted an option to purchase 38,000 shares of our common stock, which he early exercised for restricted shares of our common stock that were su

S- I/A serving on our board of directors or compensation committee. Ms. Meeker, a General Partner of Kleiner Perkins Caufield & Byers, and Mr. Botha. a Managing Member of Sequoia Capital, comprise our compensation committee. En